These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38365484)

  • 1. A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.
    Faber BW; Yeoh LM; Kurtovic L; Mol WEM; Poelert M; Smits E; Rodriguez Garcia R; Mandalawi-Van der Eijk M; van der Werff N; Voorberg-van der Wel A; Remarque EJ; Beeson JG; Kocken CHM
    Vaccine; 2024 Mar; 42(7):1785-1792. PubMed ID: 38365484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Infect Immun; 2008 Jun; 76(6):2660-70. PubMed ID: 18378635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
    Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebié I; Faber B; Remarque E; Launay O;
    Vaccine; 2017 Oct; 35(45):6218-6227. PubMed ID: 28947345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response.
    Kusi KA; Faber BW; Riasat V; Thomas AW; Kocken CH; Remarque EJ
    PLoS One; 2010 Nov; 5(11):e15391. PubMed ID: 21082025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development.
    Drew DR; Sanders PR; Weiss G; Gilson PR; Crabb BS; Beeson JG
    J Infect Dis; 2018 Jan; 217(3):498-507. PubMed ID: 29165651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits.
    Younis S; Faber BW; Kocken CHM; Remarque EJ
    BMC Immunol; 2019 Jul; 20(1):25. PubMed ID: 31362695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1).
    Arnott A; Mueller I; Ramsland PA; Siba PM; Reeder JC; Barry AE
    PLoS Negl Trop Dis; 2013; 7(10):e2506. PubMed ID: 24205419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct binding of
    Lee SK; Low LM; Andersen JF; Yeoh LM; Valenzuela Leon PC; Drew DR; Doehl JSP; Calvo E; Miller LH; Beeson JG; Gunalan K
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2215003120. PubMed ID: 36577076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity in two leading Plasmodium vivax malaria vaccine candidates AMA1 and MSP119 at three sites in India.
    Kale S; Pande V; Singh OP; Carlton JM; Mallick PK
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009652. PubMed ID: 34370745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission.
    Arnott A; Wapling J; Mueller I; Ramsland PA; Siba PM; Reeder JC; Barry AE
    Malar J; 2014 Jun; 13():233. PubMed ID: 24930015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
    Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
    PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
    Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
    Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines.
    Faber BW; Younis S; Remarque EJ; Rodriguez Garcia R; Riasat V; Walraven V; van der Werff N; van der Eijk M; Cavanagh DR; Holder AA; Thomas AW; Kocken CH
    Infect Immun; 2013 May; 81(5):1479-90. PubMed ID: 23429538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
    Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.
    Miura K; Herrera R; Diouf A; Zhou H; Mu J; Hu Z; MacDonald NJ; Reiter K; Nguyen V; Shimp RL; Singh K; Narum DL; Long CA; Miller LH
    Infect Immun; 2013 May; 81(5):1491-501. PubMed ID: 23429537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.
    Kennedy MC; Wang J; Zhang Y; Miles AP; Chitsaz F; Saul A; Long CA; Miller LH; Stowers AW
    Infect Immun; 2002 Dec; 70(12):6948-60. PubMed ID: 12438374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response.
    Bittencourt NC; Silva ABIED; Virgili NS; Schappo AP; Gervásio JHDB; Pimenta TS; Kujbida Junior MA; Ventura AMRS; Libonati RMF; Silva-Filho JL; Dos Santos HG; Lopes SCP; Lacerda MVG; Machado RLD; Costa FTM; Albrecht L
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008471. PubMed ID: 32639964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.
    Miura K; Zhou H; Muratova OV; Orcutt AC; Giersing B; Miller LH; Long CA
    Infect Immun; 2007 Dec; 75(12):5827-36. PubMed ID: 17923516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.